Contact the Public Relations Team
Moffitt’s public relations team is available to assist with your media inquiries and can provide information about the latest advances in cancer care and research. You can reach out to our public relations account coordinators or call the Strategic Communications Department at 813-456-3342. The Strategic Communications Department is open weekdays between 8 a.m. and 5 p.m. ET.
Kim Polacek, APR, CPRC
National Media Manager
National media inquiries, Clinical (Malignant Hematology, BMT)
813-456-3342
Kim.Polacek@Moffitt.org
Sara Bondell
Newsroom Manager
Clinical (Breast)
813-456-3342
Sara.Bondell@Moffitt.org
Pat Carragher
Senior Account Coordinator
Research, Clinical Trials
813-456-3342
Patrick.Carragher@Moffitt.org
Megan Myers
Account Coordinator
Clinical (GI, Lung, GYN, GU), Adolescent and Young Adult Program, Supportive Care, Foundation
813-456-3342
Megan.Myers@Moffitt.org
Steve Blanchard
Account Coordinator
Government Relations, Clinical (Cutaneous, Neuro-Oncology, Sarcoma, Head and Neck)
813-456-3342
Steve.Blanchard@Moffitt.org
Jonesa Rodriguez
Lead Internal Communications Coordinator
Internal Communications, Human Resources
813-456-3342
Jonesa.Rodriguez@Moffitt.org
Alesha Jones
Account Coordinator
Internal Communications, Chief Wellness Office, Nursing, Facilites, Pharmacy
813-456-3342
Alesha.Jones@Moffitt.org
Valentina Ahumada
Account Coordinator
Internal Communications, Patient Experience, Volunteer Services, Finance, IT
813-456-3342
Valentina.Ahumada@Moffitt.org
Amanda Sangster
Marketing and Communications Specialist
SPEROS FL, Proton therapy
813-456-3342
Amanda.Sangster@Moffitt.org
Style Guide:
The institution’s full name is H. Lee Moffitt Cancer Center & Research Institute. However, the preferred style for our institution on first reference for external communications is Moffitt Cancer Center. On the second reference and thereafter, Moffitt is the preferred proper name. Please avoid using abbreviations or incorrect styles.
For high resolution photos of the cancer center and logos, please contact the media relations team.
Media Visitation Policy:
Journalists are welcome on the campus of Moffitt Cancer Center. We can host individual reporters or crews in any of our clinical or research areas, and assist with coordinating interviews with Moffitt faculty, team members, volunteers and patients. Journalists must contact a member of our media relations team to arrange a visit. A member of our media team must meet and escort all journalists while on campus.
We have strict rules regarding patient confidentiality. Therefore, we must consent all patients before participating in media interviews.
Newsroom
- Contact the Public Relations Team
- Moffitt Experts
- Multimedia Resources
-
News and Noteworthy
- Moffitt Cancer Center Named #1 in Florida and the Southeast and #2 Cancer Hospital in the Nation by Money
- Moffitt Cancer Center is the Best Cancer Hospital in Florida and the Southeast for 2025 According to Newsweek
- The Best in Florida and the Southeast: Moffitt Named a Top U.S. Cancer Hospital for 2025–2026
- Moffitt Cancer Center Named Best Hospital (and more) in Tampa Bay Times 2024 Best of the Best Awards
- Moffitt Cancer Center is the #1 Cancer Hospital in Florida and the Southeast According to Newsweek
- Moffitt Cancer Center Named Top Cancer Hospital in Tampa Bay and Central Florida by U.S. News & World Report
- News and Noteworthy 2022
-
News Releases
- Moffitt Invites the Hispanic/Latino Community to Discuss Cancer Research
- Moffitt Researchers Develop CAR T Cells that Fight Prostate Cancer in Bone
- 11th-Annual Spring Swing® - Moffitt’s Sun Safety Tour Hits Florida Ballparks with Free Screenings
- 12th-Annual Spring Swing® — Moffitt’s Sun Safety Tour Hits Florida Ballparks with Free Screenings
- 2 Moffitt Faculty Members Named Fellows of the American Society for Radiation Oncology
- Moffitt Cancer Center Recognized on Forbes’ Best Employers for Women 2023 List
- 2018 Tampa Bay Buccaneers Rookie Class to Go Trick-or-Treating Through Moffitt Cancer Center
- 2019 Tampa Bay Buccaneers Rookie Class to Go Trick-or-Treating Through Moffitt Cancer Center
- Acidic Niche Keeps Lymphatic System in Check during Immune Response, Moffitt Researchers Say
- Adoptive Cell Therapy Plus Checkpoint Inhibitors Show Promise in Non-Small Cell Lung Cancer
- AdventHealth, Moffitt Cancer Center join forces to improve cancer care for Floridians
- After 2 Years Miles for Moffitt is Back In Person
- An Educational Intervention Can Help Vapers Use Their E-Cigarettes to Quit Smoking, Moffitt Study Finds
- Analyzing the Tumor Microenvironment at the Single Cell Level Sheds Light on Metastatic Melanoma Outcomes, Moffitt Study Shows
- And the 2018 Sapphire Award Goes To … H. Lee Moffitt!
- Augmented Reality Could Put Smoking Cessation in the Palm of Your Hand
- AutoNation Returns for the 10th Year as the Presenting Sponsor for Miles for Moffitt
- Batter Up for Moffitt’s 13th-Annual Spring Swing® Sun Safety Tour Offering Free Screenings at Florida Ballparks
- Batter Up for Moffitts 15th-Annual Spring Swing Sun Safety Tour Offering Free Screenings at Florida Ballparks
- Brass, Beats and a Break from Treatment Blend Together in Perfect Harmony at Moffitt Cancer Center
- CAR T Takes Center Stage at Moffitt Cancer Center’s Annual Sarasota Luncheon
- Charles Gibson Joins Moffitt’s National Board of Advisors
- Clinscience and OncoBay Clinical Partner to Expand Immuno-Oncology Research Globally
- Connecting Spanish-Speaking Patients with Quitline Improves Quit Rates
- COVID Infection Rates in Hillsborough County May Have Been Higher Than Reported at Height of Pandemic
- Dallas Cowboys Owner Jerry Jones Joins Moffitt Cancer Centers National Board of Advisors
- David de la Parte of Moffitt Cancer Center Named 2018 Top General Counsel
- Despite Treatment, Elderly Cancer Patients Have Worse Outcomes if HIV-Positive
- Downtown Tampa Lights Up Teal for Cervical Cancer
- Dr. Clement Gwede Elected Chair of the Florida Cancer Control Research Advisory Council
- Dr. Michael Vogelbaum joins Moffitt as Chief of Neurosurgery and Program Leader of the Department of Neuro-Oncology
- Drug Combination Targeting Heat Shock Protein 90 and BRAF is Safe and Effective in Advanced Melanoma Patients
- Dual Checkpoint Inhibitor Blockade Shows Promise as First-Line and Salvage Therapy for Merkel Cell Carcinoma Patients
- Early PSA Testing Could Help Predict Prostate Cancer among Black Men
- Ed Mullen Joins Moffitts National Board of Advisors
- Edmondo Robinson Joins Moffitt Cancer Center as New Chief Digital Innovation Officer
- Elizabeth Lindsay-Wood Joins Moffitt Cancer Center as Chief Information Officer
- Evan Zaslow Joins Moffitt Cancer Center as New Vice President of Payer Strategies
- Evidence Mounts Linking Aspirin to Lower Risk of Ovarian Cancer
- FDA Approves Expanded Use of Immunotherapy Treatment for Lung Cancer Patients
- FDA Approves Lutathera® for Treatment of Rare Form of Intestine and Colon Cancer
- FDA Approves Second CAR T Therapy for Diffuse Large B-Cell Lymphoma
- Florida Cancer Centers Awarded $1.36 Million to Fight Pancreatic Cancer
- Genomic Differences May Be Key to Overcoming Prostate Cancer Disparities Among African American Men
- Genomic Testing Can Identify African American Prostate Cancer Patients Who Have High-Risk Disease
- George Simon, M.D., Named Executive Director of Moffitt Cancer Center-AdventHealth joint Clinical Research Unit
- Gut Microbiome Influences How Lymphoma Patients Respond to CAR T Therapy
- Health Records on iPhone Now Available to Moffitt Cancer Center Patients
- Hit the Ice with Moffitt Cancer Center and Tampa Bay Lightning for Skate-A-Thon
- Hitting Clearwater Beach July 28? Join Moffitt for Free Cancer Screenings
- Immune-Activating Drug Combination is Safe and Effective in Melanoma Patients with Brain Metastases
- Inflammation from Androgen Deprivation Therapy May Cause Fatigue in Prostate Cancer Patients
- Investigational Combo Therapy Shows Benefit for TP53 Mutant MDS and Acute Myeloid Leukemia Patients
- Issam El Naqa Inducted into the 2023 Class of the American Institute for Medical and Biological Engineering College of Fellows
- It’s Not Too Late to Join Us Saturday in Downtown Tampa for Miles for Moffitt
- Jessica Schwarzkopf Honors CAR T Patient during Veterans Day Celebration at Moffitt Cancer Center
- Joseph L. Kissil, Ph.D., Named Chair of Moffitt’s Molecular Oncology Department
- Joyce Oh Joins Moffitt Cancer Center as New Vice President and Chief Information Officer
- Judge Jessica Costello Rose Baker Reilly and Dr. Edison Liu Join Moffitts Institute Board of Directors
- Krystyna Kowalczyk Named CEO of Moffitt Cancer Center’s Immunotherapy Contract Research Organization
- Local Foundation Donates $3M to Moffitt Cancer Center to Cure Rare Cancer
- Longtime Supporters Ted Couch and Connie Mack Join Moffitt’s National Board of Advisors
- Lung Cancer Cells Have Differential Signaling Responses to KRAS Inhibitor Treatment with Important Implications for Emerging Clinical Trials
- Magrolimab Plus Azacitidine Results in Promising Activity in Higher-Risk MDS Patients
- Marcia Cross Joins Moffitt’s National Board of Advisors
- Mathematical Modeling Offers New Way to Understand Variable Responses to Targeted Therapy
- Melanoma Variability at the Single-Cell Level Predicts Treatment Responses Say Moffitt Researchers
- Miles for Moffitt on Pace for In-Person Fundraiser Nov 20
- Moffitt accredited for stem cell transplant programs
- Moffitt and Sylvester Fund Projects Taking Cancer Screening and Prevention Education to the Community
- Moffitt Announces Proton Therapy Treatment Facility as Part of its Ongoing Expansion
- Moffitt Awarded CEO Cancer Gold Standard for 10th Year in a Row
- Moffitt Brings Cancer Screenings Back to Pier 60
- Moffitt Cancer Center A Best and Brightest Company to Work For in the Nation for 5th Year in a Row
- Moffitt Cancer Center A Best and Brightest Company to Work For in the Nation for the 6th Year in a Row
- Moffitt Cancer Center a Digital Health Most Wired Organization for 2nd Year in a Row
- Moffitt Cancer Center a Digital Health Most Wired Organization for 3rd Year in a Row
- Moffitt Cancer Center Advances Patient Standard of Care by Introducing Needleless Blood Draws
- Moffitt Cancer Center and AdventHealth Announce Next Step in Research Partnership
- Moffitt Cancer Center and Deerfield Management Launch Bayfield Therapeutics
- Moffitt Cancer Center and DiMe to Co-Host Cancer Moonshots New CancerX Public-Private Partnership
- Moffitt Cancer Center and Ringling College to Bring Virtual Reality to Cancer Patients
- Moffitt Cancer Center Announces Chair of New Machine Learning Department
- Moffitt Cancer Center Announces Licensing Agreement to Develop New Therapeutic Cancer Vaccine
- Moffitt Cancer Center Appoints John Cleveland as New Center Director
- Moffitt Cancer Center Asks Florida Lawmakers to Continue Investment in Cancer Research
- Moffitt Cancer Center Asks Lawmakers to Continue Support of Cancer Research
- Moffitt Cancer Center Awarded $900,000 to Study Rare Form of Melanoma
- Moffitt Cancer Center Breaks Ground on New Hospital
- Moffitt Cancer Center Breaks Ground on Speros FL Campus Jan 20
- Moffitt Cancer Center Brings Cancer Screenings Back to Pier 60
- Moffitt Cancer Center CEO Once Again Named a Physician Leader to Know
- Moffitt Cancer Center CEO, Center Director Resign after Compliance Review
- Moffitt Cancer Center Earns Blue Distinction® Specialty Care Designation for Cellular Immunotherapy CAR T
- Moffitt Cancer Center Earns High Honor for Excellence in Nursing for the Second Time
- Moffitt Cancer Center Experts to Present New Clinical Research Data
- Moffitt Cancer Center Foundation Launches COVID-19 Frontline Response Fund
- Moffitt Cancer Center Goes Pink with Hillsborough County Students
- Moffitt Cancer Center Goes Pink with Tampa Catholic High School
- Moffitt Cancer Center Hires Artificial Intelligence Officer
- Moffitt Cancer Center Hires Maria Muller as New Leader of Its Foundation
- Moffitt Cancer Center Hires New Vice Chair of the Department of Genitourinary Oncology
- Moffitt Cancer Center Hires New Vice President of Facilities and Support Services
- Moffitt Cancer Center Hires New Vice President of Partnership Development
- Moffitt Cancer Center Honored for Innovation in Palliative Care
- Moffitt Cancer Center Honors Military Mother with Metastatic Breast Cancer on Veterans Day
- Moffitt Cancer Center Hosts Miles for Moffitt Presented by AutoNation
- Moffitt Cancer Center HPV Expert Receives Award from American Cancer Society
- Moffitt Cancer Center Introduces Speros FL Its 775 Acre Pasco County Global Innovation Center
- Moffitt Cancer Center Invites Hispanic Community to Latinos y el Cáncer
- Moffitt Cancer Center Joins Dana-Farber Cancer Institute to Help Stop Blood Cancer
- Moffitt Cancer Center Joins Forces with AdventHealth to Expand Cancer Care in the Tampa Bay Region
- Moffitt Cancer Center Joins Weill Cornell Medicine and University of North Carolina to Improve HIV-Related Cancer Care Abroad
- Moffitt Cancer Center Launches Immunotherapy Contract Research Organization
- Moffitt Cancer Center Leads the Nation in Addressing LGBTQ Health Care Disparities and Education
- Moffitt Cancer Center Makes Computerworld’s 2020 List of 100 Best Places to Work in IT
- Moffitt Cancer Center Named a 2019 NAFE Top 10 Nonprofit Company for Executive Women
- Moffitt Cancer Center Named a Best and Brightest Company to Work For in The Nation
- Moffitt Cancer Center Named a Tampa Bay Times Top Workplace for the Eighth Time
- Moffitt Cancer Center Named a Tampa Bay Times Top Workplace for the Ninth Time
- Moffitt Cancer Center Named Best and Brightest Company to Work For in the Nation
- Moffitt Cancer Center Named One of HealthCare’s Most Wired Organizations
- Moffitt Cancer Center Named One of Working Mother Magazine’s 100 Best Companies for 10th Time
- Moffitt Cancer Center Names 3 New Research Leaders
- Moffitt Cancer Center Names Chip Fletcher, Esq. as the New Vice President, Deputy General Counsel
- Moffitt Cancer Center Names Jarett Rieger Vice President and Chief Innovation Officer
- Moffitt Cancer Center Names Kelley Gonzalvo as the new Chief Nursing Officer
- Moffitt Cancer Center Names Ken Komorny as the New Vice President of Pharmacy
- Moffitt Cancer Center Names New Clinical Science Research Leaders
- Moffitt Cancer Center Names Patrick Hwu MD as President and CEO
- Moffitt Cancer Center Names Vice Chair of Immunology Department
- Moffitt Cancer Center Offers Free Head, Neck and Oral Cancer Screenings in Puerto Rico
- Moffitt Cancer Center Offers Free Seminar on Eliminating Cervical Cancer in Puerto Rico
- Moffitt Cancer Center ofrece consejos gratuitos de salud mental a los cuidadores puertorriqueños tras el paso del huracán María
- Moffitt Cancer Center Once Again Named a Best and Brightest Company to Work For
- Moffitt Cancer Center Partners with IBA for Proton Therapy
- Moffitt Cancer Center Partners with Nation’s Top Cancer Centers to Endorse Goal of Eliminating HPV-related Cancers in the United States
- Moffitt Cancer Center Partners with New Blood Banks to Fulfill Growing Needs of Patients
- Moffitt Cancer Center Partners with Top Cancer Centers for Urgent Call to Get Cancer-Preventing HPV Vaccination Back on Track
- Moffitt Cancer Center Partners with TuHURA Biopharma Inc. to Develop a New Generation of Targeted Immunotherapies
- Moffitt Cancer Center Physician Admitted into American College of Surgeons Academy of Master Surgeon Educators
- Moffitt Cancer Center Physician Receives NCI Cancer Clinical Investigator Team Leadership Award
- Moffitt Cancer Center presents La Ciudad se Viste de Rosa May 21
- Moffitt Cancer Center Receives $10 Million from It Works! Founder to Establish Research Center for Rare Blood Cancer
- Moffitt Cancer Center Receives 2018 Press Ganey Guardian of Excellence Award for Outstanding Performance in Patient Experience for Fourth Time
- Moffitt Cancer Center Receives 2019 Press Ganey Guardian of Excellence Award for Outstanding Performance in Patient Experience for Fifth Time
- Moffitt Cancer Center Recognized as Tampa Bay Times Top Workplace for 10th Time
- Moffitt Cancer Center Recognized as Tampa Bay Times Top Workplace for 11th Time
- Moffitt Cancer Center Recognized as Tampa Bay Times Top Workplace for 12 Time
- Moffitt Cancer Center Recognized as Winner of Project Management Institute 2021 PMI Professional Awards
- Moffitt Cancer Center Recognized by the American Medical Association’s Joy in Medicine Health System Recognition Program
- Moffitt Cancer Center Recognized on Forbes America’s Best Large Employers List
- Moffitt Cancer Center Researcher Receives $200,000 Grant to Investigate Pancreatic Cancer
- Moffitt Cancer Center Researchers Compare Chemotherapy Regimens for Best Outcomes in Invasive Bladder Cancer
- Moffitt Cancer Center Researchers Develop Interactive Tool to Estimate Genetic Diversity and Ancestry of Cancer Cell Lines
- Moffitt Cancer Center Researchers Find BRAF Protein Modification Could Slow Tumor Growth
- Moffitt Cancer Center Researchers Identify Mechanism of Resistance to BRAF Inhibitors in Melanoma
- Moffitt Cancer Center Researchers Identify One Way T Cell Function May Fail in Cancer
- Moffitt Cancer Center Showcases Research and Innovation at 12th Annual Business of Biotech Conference
- Moffitt Cancer Center Showcases Research and Innovation at 13th Annual Business of Biotech Conference
- Moffitt Cancer Center Showcases Research and Innovation at 14th Annual Business of Biotech Conference
- Moffitt Cancer Center Shows Appreciation for STEM Teachers on Valentine’s Day
- Moffitt Cancer Center Spreads Love to Teachers on Valentine’s Day
- Moffitt Cancer Center Studies How E-Cigarettes Help Smokers Quit
- Moffitt Cancer Center Study Suggests More Could Benefit from CAR T-Cell Therapy
- Moffitt Cancer Center Takes Business of Biotech Conference Virtual
- Moffitt Cancer Center Teams Up with Port Tampa Bay and the Tampa Bay Lightning to Bring Cancer Community Outreach to Channelside
- Moffitt Cancer Center to Advance Breast Cancer Immunotherapy Research with $8.3 Million Grant from Department of Defense
- Moffitt Cancer Center to Close Sept. 28 and 29 for Hurricane Ian
- Moffitt Cancer Center To Expand in South Hillsborough County to Serve More Patients
- Moffitt Cancer Center To Honor Air Force Veteran and Leukemia Survivor
- Moffitt Cancer Center To Honor Army Lieutenant Colonel Breast Cancer Survivor
- Moffitt Cancer Center to Resume Operations after Hurricane Ian Beginning Oct. 1
- Moffitt Cancer Center Welcomes Five New Research Recruits
- Moffitt Cancer Center, USF Health Host 2018 Global Cardio-Oncology Summit
- Moffitt Cancer Center’s Chief Information Security Officer Named as a Fellow to America’s Cybersecurity Think Tank
- Moffitt Cancer Center’s Dr. Steven Eschrich Named to National Academy of Inventors
- Moffitt Cancer Center’s Healthy KIDZ Program To Award $24,000 in Scholarships to High School Seniors
- Moffitt Cancer Center’s Healthy KIDZ Program to Give Local Students Dose of Health Care Experience
- Moffitt Cancer Center’s National Cancer Institute Designation Renewed
- Moffitt CEO Alan List Named to Becker’s Hospital Review’s 112 Physician Leaders of Hospitals and Health Systems for Fourth Time
- Moffitt CEO Dr. Alan List Selected for Florida Council of 100
- Moffitt Gets Boost in State Funding to Support Pasco County Project
- Moffitt Investigators Identify STING Gene Methylation Allows Melanoma to Evade the Immune System
- Moffitt Invites Hispanic Community to Latinos y el Cáncer
- Moffitt is the No. 11 Cancer Hospital in the Nation, Based on U.S. News World Report
- Moffitt named to Computerworld’s 2018 List of 100 Best Places to Work in IT
- Moffitt Named to United Way Suncoast’s ‘Most Generous Workplaces’ List
- Moffitt Names Dr. Elsa R. Flores Associate Center Director of Basic Science
- Moffitt Offers Free Cancer Screenings July 27 at Clearwater Beach’s Pier 60
- Moffitt Once Again a Top 10 Cancer Hospital Based on U.S. News World Report
- Moffitt Partners with Two VA Hospitals to Expand Clinical Cancer Research
- Moffitt Physician Receives NCI Cancer Clinical Investigator Team Leadership Award
- Moffitt Physicians Lead International Study to Identify Melanoma Patients with High-Risk Disease
- Moffitt President and CEO Dr. Alan List Inducted into the 2019 Florida Inventors Hall of Fame
- Moffitt Program Bringing Patients, Scientists Together Infuses New Meaning into Research
- Moffitt Receives $10.2 Million Grant to Develop New Lung Cancer Therapies
- Moffitt Receives 5 Million to Support Oral Cancer Research
- Moffitt Research of Selinexor for Relapsed/Refractory Multiple Myeloma Facilitates Recent FDA Approval
- Moffitt Researcher Awarded World Molecular Imaging Society Gold Medal
- Moffitt Researcher Receives NIH Directors New Innovator Award
- Moffitt Researchers Analyze VA Data to Study Prostate Cancer Disparities
- Moffitt Researchers Characterize Mechanism of Action of CAR T Cells
- Moffitt Researchers Complete Largest Genomic Analysis of Merkel Cell Carcinoma Patients
- Moffitt Researchers Contribute to Discovery of Mechanism Leading to Drug Resistance in Prostate Cancer
- Moffitt Researchers Create Chimeric Antigen Receptor Mutations to Enhance CAR T Cell Activity and Survival
- Moffitt Researchers Create Software Program that Allows Simultaneous Viewing of Tissue Images Through Dimensionality Reduction
- Moffitt Researchers Demonstrate Tissue Architecture Regulates Tumor Evolution: Location Matters
- Moffitt Researchers Determine 1st Crystal Structure of LAG3
- Moffitt Researchers Develop First Patient Derived Cells to Study Leptomeningeal Disease
- Moffitt Researchers Develop HER3-Specific Dendritic Cell Cancer Vaccine
- Moffitt Researchers Develop Mathematical Model to Predict Patient Outcomes to Adaptive Prostate Cancer Therapy
- Moffitt Researchers Develop Model to Personalize Radiation Treatment for Breast Cancer Patients
- Moffitt Researchers Develop Model to Predict Non-Small Cell Lung Cancer Patient Outcomes to Immunotherapy
- Moffitt Researchers Develop Model to Predict Patients with Poor Lung Cancer Outcomes
- Moffitt Researchers Develop Model to Predict Prostate Cancer Aggressiveness
- Moffitt Researchers Develop More Efficient Approach to Create Mouse Models
- Moffitt Researchers Develop Non-invasive Approach to Measure Biomarker Levels, Predict Outcomes in Lung Cancer Patients
- Moffitt Researchers Develop Technology that Allows First Visualization of Radiation Therapy in a Patient in Real Time
- Moffitt Researchers Develop Tool to Better Predict Treatment Course for Lung Cancer Patients
- Moffitt Researchers Develop Tool to Detect Patients at High Risk for Poor Lung Cancer Outcomes
- Moffitt Researchers Develop Tool to Measure Patient Health and Well-Being after Radionuclide Therapy
- Moffitt Researchers Discover Biochemical Pathway That Protects Cells from Ferroptosis Cell Death
- Moffitt Researchers Discover Cancer-associated Fibroblasts Induce Drug Sensitivity
- Moffitt Researchers Discover Connection Between Stress-Activated Signaling and Immune Cell Evasion in Melanoma
- Moffitt Researchers Discover DNA Copy Number Alterations Lead to Changes in RNA Circuits that Impact Melanoma Metastasis
- Moffitt Researchers Discover Mechanism Controlling Tertiary Lymphoid Structure Formation in Tumors
- Moffitt Researchers Discover Mechanism that Regulates Anti-Tumor Activity of Immune Cells in Ovarian Cancer
- Moffitt Researchers Discover New Approach to Stimulate an Immune Response Against Tumor Cells
- Moffitt Researchers Discover New Pathways to Activate Dendritic Cells, Produce Strong Anti-Tumor Immunity
- Moffitt Researchers Discover New Target for CAR T Cells in Solid Tumors
- Moffitt Researchers Discover Novel Role of Specific Histone Deacetylase in Non-Small Cell Lung Cancer
- Moffitt Researchers Discover Pathway Critical for Lymphoma Development
- Moffitt Researchers Discover Possible New Treatment Strategy for Lung Cancer
- Moffitt Researchers Discover Potential New Drug Target to Treat Cutaneous T Cell Lymphoma
- Moffitt Researchers Discover Regulatory Pathway That Blocks Immune Response Against Cancer
- Moffitt Researchers Discover Specific Molecules that Promote Cancer Progression
- Moffitt Researchers Discover Two-Pronged Approach to Stimulate STING Antitumor Activity
- Moffitt Researchers Find Dual Inhibitor May Be Safer for Chronic Lymphocytic Leukemia Patients
- Moffitt Researchers Identify a Mechanism Controlling Tumor Cell Recognition by Immune Cells
- Moffitt Researchers Identify Driver of Further Metastasis in BRAF Inhibitor Resistant Melanoma
- Moffitt Researchers Identify Effective Drug Combination Against Uveal Melanoma in Preclinical Studies
- Moffitt Researchers Identify Factors Associated with COVID-19 Vaccination Acceptance Among Cancer Patients
- Moffitt Researchers Identify Factors to Predict Severe Toxicities in CAR T Patients
- Moffitt Researchers Identify Genomic and Immune Indicators That Predict Lethal Outcomes in High-Grade Prostate Cancer
- Moffitt Researchers Identify How Cancer Cells Adapt to Survive Harsh Tumor Microenvironments
- Moffitt Researchers Identify Immunosuppression as a Key Factor Leading to Colorectal Cancer Development
- Moffitt Researchers Identify Key Characteristics of Immune Cells in Ovarian Cancer
- Moffitt Researchers Identify Key Factors Impacting Adaptive Therapy
- Moffitt Researchers Identify Key Genomic Alterations and Potential Therapeutic Vulnerabilities in Transformed Cutaneous TCell Lymphoma
- Moffitt Researchers Identify Mechanism Controlling DNA Repair
- Moffitt Researchers Identify Molecular Characteristics of Leptomeningeal Melanoma Metastases
- Moffitt Researchers Identify Molecular Pathway That Controls Immunosuppression in Tumors
- Moffitt Researchers Identify New Relevant Target for PARP Inhibitor Talazoparib
- Moffitt Researchers Identify New Target to Reduce Risk of Graft-Versus-Host Disease
- Moffitt Researchers Identify Novel Mechanism to Thwart KRas-driven Tumor Growth
- Moffitt Researchers Identify Novel Therapeutic Targets in Cutaneous Squamous Cell Carcinoma
- Moffitt Researchers Identify Pathway that Regulates Angiogenesis in Tumors
- Moffitt Researchers Identify Pathway that Regulates Lipid Synthesis and Contributes to Tumor Survival
- Moffitt Researchers Identify Protein that Causes Epithelial Cancers to Spread
- Moffitt Researchers Identify Splice Variant Biomarkers in Clear Cell Renal Cell Carcinoma
- Moffitt Researchers Identify Subtypes of Squamous Cell Lung Cancer
- Moffitt Researchers Identify Tumor-Based Methylation Patterns as Cancer Biomarkers
- Moffitt Researchers Identify Why CAR T Therapy May Fail in Some Lymphoma Patients
- Moffitt Researchers Perform Comprehensive Analysis of Cellular and Molecular Characteristics of Acral Melanoma
- Moffitt Researchers Say Multiple Drug Adaptive Therapy is Possible
- Moffitt Researchers Show Beta-Cutaneous HPV May Be Predictor of Squamous Cell Carcinoma
- Moffitt Researchers Show Sequential Treatment with Immunotherapy and Targeted Therapy Prolongs Anti-Tumor Activity
- Moffitt Researchers Unlock Immune Cell Contributions that Could Lead to New Therapies for Endometrial Cancer
- Moffitt Researchers Use Computer Modeling to Predict Patient Tumor Responses to Radiation Therapy
- Moffitt Researchers Use Mathematical Modeling and Evolutionary Principles To Show Importance of Basing Treatment Decisions on Tumor Responses
- Moffitt Researchers Use Mathematical Modeling to Analyze Dynamics of CAR T-Cell Therapy
- Moffitt Researchers Use Mathematical Modeling to Explain Immunotherapy Responses
- Moffitt Researchers Use Mathematical Modeling to Identify Factors that Determine Adaptive Therapy Success
- Moffitt Researchers Use New Technique to Identify a Novel Drug Combination for Non-Small Cell Lung Cancer
- Moffitt Researchers Use Single-Cell Imaging and Mathematical Modeling to Determine Effective Drug Properties
- Moffitt Study Finds Cancer Patients Do Benefit From COVID-19 Vaccination
- Moffitt Study Shows Adaptive Therapy Improves Outcomes Reduces Care Costs for Prostate Cancer Patients
- Moffitt Study Shows Lymphoma Patients Can Benefit from Receiving CAR T Sooner
- Moffitt Welcomes Nobel Laureate for Ted Couch Cancer Research Lecture Series
- Moffitt’s Chief Information Security Officer Named to Federal Advisory Committee
- Moffitt’s Curbside Clinic Gives Patients Access To Treatment from Their Car
- Moffitt’s Dave Summitt Named Chief Information Security Officer of the Year
- Moffitt’s Dr. Vani Simmons Honored with ASPO’s Joseph W. Cullen Memorial Award
- Moffitt’s Merritt Martin Named Tampa Bay Business Journal BusinessWoman of the Year Honoree
- Moffitt's Chief Compliance Officer Featured in Compliance Today Magazine
- Mom with Metastatic Breast Cancer Raises Money for Cancer Research by Walking in Miles for Moffitt Presented by AutoNation
- Mutation Profile of Acral Nevi Differs from Acral Melanoma, Moffitt Researchers Say
- NAFE names Moffitt Cancer Center one of the Top 10 Nonprofit Companies for Executive Women
- Nation’s Top Cancer Organizations Partner to Endorse Initiative to Increase Lung Cancer Screening in the United States
- Neoadjuvant Pembrolizumab Administered Before Surgery Improves Outcomes of Melanoma Patients
- New CAR T Case Study Shows Promise in Acute Myeloid Leukemia
- New Drug Combination Shows Promising Activity in Non-Small Cell Lung Cancer Patients
- New Smoking Cessation Intervention Helps Patients with Cervical Cancer Precursor or Cervical Cancer Quit Smoking
- New State Legislative Director Joins Moffitt Cancer Center
- New Studies Show Daily Aspirin Use Reduces Ovarian Cancer Risk and Improves Survival after Diagnosis
- New Study Highlights CAR T-cell Therapy Success for Lymphoma When Used as Standard of Care
- New Study Views Cancer Treatment as a Game to Find Strategies That Improve Patient Outcomes
- New Two-year Data Show 39 Percent of Non-Hodgkin Lymphoma Patients Treated with CAR T-cell Therapy Remain in Remission
- New USF President Joins Moffitt Cancer Center’s Institute Board
- Newly-Approved Therapy Provides Improved Quality of Life for Patients with Advanced Metastatic Midgut Neuroendocrine Tumors
- Non-Small Cell Lung Cancer Patients See Improved Survival with Durvalumab
- Novel Therapy Shows Promise for Lung Cancer Patients with Rare EGFR Mutation
- Olympic Gold Medalist Scott Hamilton Releases Children’s Book to Help Parents Talk to Kids about Cancer
- Oncolytic Virus Treatment Produces Promising Results in Patients with Triple-Negative Breast Cancer
- Out of Space, Moffitt Cancer Center Seeking Urgent State Support
- Pamela Mars Wright Joins Moffitts National Board of Advisors
- Panera Bread Goes Pink for Moffitt Cancer Center
- Paramount Pictures Futurist Joins Moffitt Cancer Center’s National Board of Advisors
- Patients Treated with Immune Checkpoint Inhibitors Have Better Quality of Life, Moffitt Analysis Shows
- Post-Traumatic Stress Disorder Linked to Increased Risk of Ovarian Cancer
- Rare Melanoma Type Highly Responsive to Immunotherapy
- Registration Open for Miles for Moffitt Presented by AutoNation
- Researchers Pinpoint Why Lymphoma Patients May Become Resistant to Specific Therapy, Identify Strategy to Overcome It
- Robert Rothman Joins Moffitt’s National Board of Advisors
- Santosh Mohan Joins Moffitt Cancer Center as New Vice President of Digital
- Screening High-Risk Individuals Can Reduce Multiple Myeloma Mortality
- Small Cell Lung Cancer Patients Who Have Failed Previous Therapies Now Have New Hope — the First in 20 Years
- SpaceX to Take Moffitt Investigators’ Experiment to the International Space Station
- Specific Cancer Driving Protein Plays Important Role in Lung Cancer Development, Moffitt Researchers Say
- Spontaneous Cell Fusions Amplify Genetic Diversity Within Tumors, Moffitt Researchers Say
- Stereotactic Body Radiotherapy Is an Effective Treatment for Patients with Lung Neuroendocrine Tumors
- Tampa Bay Buccaneers Moffitt Cancer Center Team Up for Men’s Health Huddle
- Tampa Bay Mascots Motivate Patients with a Flash Mob at Moffitt Cancer Center
- The Rapid Tissue Donation Program at Moffitt Cancer Center Offers a Feasible Approach to Improve Research
- Therapeutic Strategies Based on Evolutionary Principles May Be Key to Improving Patient Outcomes
- Thomas Rouse Joins Moffitt’s National Board of Advisors
- Turnstone Biologics and Moffitt Cancer Center Announce Strategic Alliance to Advance Next-Generation TIL Therapies for Solid Tumors
- U.S. Reps. Neal Dunn, Debbie Wasserman Schultz Honored with Moffitt Momentum Award
- Virtual Miles for Moffitt Oct. 24 Lets You Pound the Pavement Anywhere
- WINSTON | BAKER Co-Founder Amy Baker Joins Moffitt’s National Board of Advisors
- Work-Life Balance, Career Development and Mission Keep Moffitt Cancer Center on Computerworld’s List of 100 Best Places to Work in IT
- Jack McKenna Joins Moffitt Cancer Center as New Chief Human Resources Officer
- Young Patients See Strength in Numbers at Moffitt’s Pediatric Melanoma Clinic Day
- Moffitt and YMCA of the Suncoast Team Up to Improve Wellness Among Cancer Survivors
- Xavier Avat Joins Moffitt Cancer Center as New Chief Business Officer
- Moffitt Cancer Center Taps W. Gregory Sawyer, Ph.D., as Inaugural Chair of the Department of Bioengineering
- Moffitt Cancer Center Launches New Corporations and Board for SPEROS FL
- Ashley Bell Barnett, Sareet Majumdar and Dr. Katherine Chung-Bridges Join Moffitt’s Board
- Moffitt Cancer Center Named Top 10 Cancer Hospital in Nation by Newsweek
- Moffitt Investigates Association between Inflammation and Treatment Related Symptoms in Gynecologic Cancers
- Moffitt Cancer Center at Port Tampa Bay Offers Community Outreach and Education
- Breast Cancer Survivors Experience Faster Biological Aging Compared to Cancer-Free Women
- Moffitt Cancer Center Celebrates Grand Opening of Moffitt McKinley Hospital
- Moffitt Cancer Center a Best and Brightest Company to Work For in the Nation for the 7th Year in a Row
- Moffitt Names Paulo Rodriguez, Ph.D., Chair of the Department of Immunology and Co-Leader of the Immuno-Oncology Program
- FDA Approves HEPZATO Kit to Treat Metastatic Ocular Melanoma
- Moffitt Researchers Use Mathematical Modeling and Dynamic Biomarkers to Characterize Metastatic Disease During Adaptive Therapy
- Moffitt Awarded $5.5 Million to Study Virus-Associated Tumors Among Those Living with HIV in Sub-Saharan Africa
- Moffitt Cancer Center Recognized on Forbes’ America’s Best-in-State Employers 2023 List
- Moffitt Receives $3 Million to Develop New Targeted Treatments for Rare Melanomas
- Oral Health Linked to Head and Neck Cancer Risk and Survival
- Moffitt Receives $10.4 Million to Develop Treatment Strategies to Overcome Drug Resistance in Lung Cancer
- Moffitt Cancer Center Named a 2023 Elite Winner of the Best and Brightest Companies to Work for in the Nation
- Novel Drug, NFX-179, Inhibits MEK Activity, Prevents Cutaneous Squamous Cell Carcinoma Development
- Moffitt Cancer Center Recognized as a Digital Health Most Wired Organization
- CFO Jimmy Patronis Returns $149,000 in Unclaimed Property to Moffitt Cancer Center
- Moffitt Research Finds Non-Small Cell Lung Cancer Drug Lorlatinib Targets Additional Protein
- Moffitt’s W. Gregory Sawyer, Ph.D., Awarded BioFlorida’s Entrepreneur of the Year
- 2023 Tampa Bay Buccaneers Rookie Class To Tour Moffitt Cancer Center McKinley Hospital
- CancerX Launches New Startup Accelerator to Advance Digital Innovations in Oncology
- Moffitt Cancer Center To Honor Air Force F-16 Fighter Pilot Testicular Cancer Survivor
- Rev up Your Sneakers: Miles for Moffitt Takes Over Downtown Tampa This Saturday
- Moffitt Researchers Identify Cell Signaling Pathway Controlling Melanoma Cell Metastasis to the Brain
- Moffitt Receives $3.6 Million Grant to Evaluate Screening Test for Oropharyngeal Cancers
- Moffitt Cancer Center Makes Computerworld’s 2024 List of Best Places to Work in IT
- Moffitt Researchers Identify Key Mechanisms of Action Differences in 2 Immune Checkpoint Inhibitor Combination Therapies for Advanced Melanoma
- Moffitt Researchers Identify Pathway that Controls Breast Cancer Metastasis to the Brain
- Moffitt Researchers Characterize the Tumor Suppressor Activity of the PTEN Protein in Melanoma
- Deregulation of Alternative RNA Splicing Promotes Pancreatic Cancer Progression and Metastasis
- Researchers Identify Key Characteristics Associated with Improved CAR T Outcomes in Large B Cell Lymphoma
- New Reagent Improves the Process of Making Sulfur-Containing Compounds that May Be Used in Medicines
- Dr. Karen Lu Joins Moffitt Cancer Center as New Executive Vice President, Physician in Chief
- Moffitt Study Suggests Improvements Needed for Patient-Reported Outcome Data in Genitourinary Cancer Clinical Studies
- Moffitt Develops First Individualized Predictive Model for Multiple Myeloma Treatment
- Moffitt Study Highlights Urgent Need to Address Impact of Extreme Weather Events on Cancer Survivorship
- Moffitt Study Finds Neoadjuvant Chemotherapy Significantly Improves Outcomes for Penile Squamous Cell Carcinoma Patients
- Moffitt Plays Pivotal Role in FDA Approval of Tumor-Infiltrating Lymphocyte Therapy for Advanced Melanoma
- CancerX Announces Inaugural Start-Up Accelerator Cohort
- Moffitt Researcher First in Florida to Receive Damon Runyon-Rachleff Innovation Award
- Moffitt Cancer Center Receives Press Ganey Human Experience Award for Patient Experience
- Ken Jones Appointed to Moffitt Cancer Center’s Institute Board of Directors
- Moffitt Cancer Center Recognized as a Tampa Bay Times Top Workplace for 13th Time
- Moffitt Cancer Center to Revolutionize Cancer Care Delivery Using AI and Machine Learning with NVIDIA, Oracle and Deloitte
- Registration Open for 2024 Miles for Moffitt Presented by AutoNation
- Moffitt Treats First Clinical Trial Patient with Gamma Delta CAR T for Bone Metastatic Prostate Cancer
- Moffitt Researchers Discover New Therapeutic Target for Non-Small Cell Lung Cancer
- Moffitt Study Suggests Cells Possess Hidden Communication System
- Moffitt Initiates Groundbreaking Clinical Trial with Oncolytic Virus for Non-Small Cell Lung Cancer
- Oncology Nursing Certification Corporation Employer Recognition Award Goes to Moffitt
- Moffitt Cancer Center and Fulgent Pharma Join Forces To Revolutionize Cancer Therapeutics
- Joanna Weiss Appointed Moffitt’s Chief Financial Officer
- Moffitt Cancer Center Uses AI to Develop More Personalized Cancer Treatment Strategies
- Moffitt Cancer Center and Virogen Biotechnology Forge Groundbreaking Partnership to Accelerate Oncology and Immunotherapy Innovations
- Innovative Combination Therapy Shows Promise for Bladder Cancer Patients Unresponsive to Standard Treatment
- Engineering Cancer’s End: Moffitt Scientists Say Bioengineering Will Change Our Ability to Research and Treat Cancer
- Moffitt Study Reveals New Mechanism of Drug Resistance in Melanoma Leptomeningeal Disease
- Moffitt Cancer Center Achieves Prestigious Nursing Magnet Recognition
- Revolutionizing Ovarian Cancer Treatment With Adaptive PARP Inhibitor Therapy
- Moffitt Researchers Develop Synthesis Method to Enhance Access to Cancer-Fighting Withanolides
- Chip Fletcher, Esq., Appointed as Moffitt Cancer Center’s General Counsel
- Tumor-Infiltrating Lymphocyte Therapy Marks a Milestone in Cancer Treatment
- Moffitt Study Uncovers Key Immune Cells for Combating Aggressive Merkel Cell Carcinoma
- New Moffitt Study Explores How Antifragility Could Revolutionize Cancer Treatment
- Moffitt Consortium Study Answers Questions About Long-Term Survivorship Following CAR T Treatment
- Moffitt Researchers Develop New Chemical Method to Enhance Drug Discovery
- Moffitt Researchers Reveal Key LAG3 Mechanisms That Could Transform Cancer Immunotherapy
- Moffitt Cancer Center Announces Strategic Collaboration with AstraZeneca to Accelerate Oncology Cell Therapies
- Moffitt Cancer Center and CMIC Group Announce Strategic Partnership to Accelerate Global Cancer Clinical Trials
- Moffitt Cancer Center Earns North America's Project Management Office of the Year
- Moffitt Study Unveils the Role of Gamma-Delta T Cells in Cancer Immunology
- Moffitt Cancer Center Named a Best and Brightest Company to Work for in the Nation
- Moffitt Study Reveals Insights Into Oral HPV Incidence and Risks in Men Across 3 Countries
- Moffitt Cancer Center Earns American Medical Association Joy in Medicine Honor
- CancerX Launches Expanded Accelerator Program for 2025, Partnering With KidsX to Transform Cancer Care Innovation
- Moffitt Cancer Center Bioengineer Receives Prestigious Tribology Gold Medal
- Moffitt Cancer Center Earns Family Friendly Business Award
- Moffitt Cancer Center Achieves Distinction as a 2024 Digital Health Most Wired Organization
- Moffitt Study Links Methylmalonic Acid to Weakening of Immune Cells in Lung Cancer
- Moffitt Cancer Center to Offer Mobile Lung Cancer Screenings to Pasco County Residents
- Moffitt Study Reveals Promising Combination Therapy for Bladder Cancer
- Moffitt Study Shows Immune Structures in Melanoma Could Help Predict Patient Survival
- Moffitt Study Shows How Cancer Cell Death May Harm the Immune System and Promote Tumor Growth
- Moffitt Cancer Center Announces the 2024 National Academy of Inventors Fellows
- Moffitt Cancer Center Ranks No. 14 Among Large Organizations on Computerworld’s 2025 Best Places to Work in IT List
- Moffitt Cancer Center and SPEROS FL Announce Hope Innovation District
- Tiffany Carson, Ph.D., Elected as Fellow in the Academy of Behavioral Medicine Research
- Moffitt Cancer Center and Cryoport Announce Strategic Collaboration
- Moffitt Cancer Center Named a Best and Brightest Company to Work For in the Nation
- Moffitt Study Shows How Genomic Tests Could Help Treat Prostate Cancer More Effectively
- Moffitt Research Advocates for Routine Brain MRI Screening in Asymptomatic Late Stage Breast Cancer Patients
- Moffitt Study Shows AI Boosts Efficacy of Cancer Treatment, But Doctors Remain Key
- Moffitt Cancer Center Is First Health System in Tampa Bay Area To Receive Proton Therapy System for Cancer Treatment
- Moffitt Study Finds Key Biomarker to Predict KRASG12C Inhibitor Effectiveness in Lung Cancer
- Pickleball Program Boosts Health and Wellness for Cancer Survivors, Moffitt Study Finds
- Moffitt’s Magnolia Ball Raises More Than $8 Million for Cancer Research
- Moffitt Cancer Center Named a 2025 Women’s Choice Award Winner for Best Hospitals
- H. Lee Moffitt Named Outstanding Citizen of the Year
- Moffitt Cancer Center and 1ST Biotherapeutics Announce Strategic Alliance To Transform Cancer Treatment
- Moffitt Study Identifies Immune Response That May Stop Breast Cancer from Spreading
- CancerX Launches 2025 Accelerator to Drive Innovation in Oncology
- Moffitt Becomes First Cancer Center To Open Nikon Center of Excellence
- Moffitt Cancer Center Announces Dr. Josh Carpenter as President of SPEROS FL
- Moffitt Cancer Center Receives 2024 Press Ganey Human Experience Awards
- Moffitt Study Finds New Immunotherapy Strategy for Enhancing Melanoma Treatment
- Moffitt Study Finds Vaccine May Improve Breast Cancer Treatment Outcomes
- Moffitt Cancer Center To Offer Inpatient Hospice Services
- Moffitt Led Study Finds Keys to Brain Cancer Growth, May Help Improve Treatments
- Moffitt-Led International Study Finds New Drug Delivery System Effective Against Rare Eye Cancer
- Moffitt Study Shows New Immune Boost Could Expand Access to Cancer Immunotherapy
- Registration Is Open for 2025 Miles for Moffitt Presented by AutoNation
- Michael J. Schell, Ph.D. Elected Fellow of the American Statistical Association
- Moffitt Cancer Center Celebrates Construction Milestones at SPEROS FL with Installation of Proton Therapy System and Topping Out
- Moffitt Cancer Center Announces Strategic Collaboration With Galapagos To Transform CAR T Manufacturing in the Southeast
- Moffitt Cancer Center Launches New Podcast, The ImmunoVerse, Hosted by CEO Dr. Patrick Hwu
- Moffitt Study Uncovers a Way to Boost Treatment for Aggressive Melanoma
- Moffitt Cancer Center Recognized as a Tampa Bay Times Top Workplace for the 14th Time
- Moffitt Study Finds Structural Barriers May Prevent Cancer Care for People Living With HIV
- Moffitt Researchers Show That Reactivity to Tumor Antigens is Important for TIL Therapy
- Moffitt and Tampa YMCA Partner to Expand Cancer Survivorship Program
- Largest Genomic Study of Veterans with Metastatic Prostate Cancer Reveals Critical Insights for Precision Medicine
- W. Gregory Sawyer Ph.D. Named Inductee to Florida Inventors Hall of Fame 2025 Class
- Moffitt Cancer Center and cTRL Therapeutics Partner To Develop Next-Generation Cell Therapies for Cancer Patients
- Moffitt Cancer Center Launches Study to Improve Advanced Lung Cancer Outcomes in the Black Community
- Moffitt Study Finds Promising New Combo Therapy for Drug-Resistant Melanoma
- PathAI and Moffitt Cancer Center Announce Strategic Collaboration to Deploy the AISight® Dx Digital Pathology Platform and Advance AI Diagnostics
- Moffitt Study Uncovers New Mechanism of Immunotherapy Resistance
- Moffitt Study Finds Lymphoma Accelerates Aging of Immune Cells and Tissues
- Moffitt Develops First Genetically Engineered Cancer Model in Naked Mole Rats
- Tampa Bay Mascots Motivate Patients with a Flash Mob at Moffitt Cancer Center
- Moffitt Researchers Develop Machine Learning Model to Predict Urgent Care Visits for Lung Cancer Patients
- Moffitt Cancer Center Recognized as a 2025 Best and Brightest Company to Work for in the Nation
- Moffitt Cancer Center and Mainsail Lodging & Development Announce Partnership To Develop Full-Service Hotel on Moffitt’s McKinley Campus
- Moffitt Cancer Center Launches AccelerOnc Studio, First U.S. Venture Studio for Oncology
- Moffitt Study Supports Gene-Tailored Radiation Doses To Treat HPV-Positive Throat Cancer
- Moffitt Study Shows Promise for New Treatment in Patients With Leptomeningeal Disease
- Moffitt Cancer Center Receives $22.4 Million Grant to Advance Research and Clinical Trials for Leptomeningeal Disease
- Moffitt Cancer Center Partners with AbbVie to Advance New Cancer Treatments
- AccelerOnc, Nation’s First Venture Studio for Digital Oncology, Unveils Portfolio
- CancerX Unveils New Leadership Model to Strengthen Cancer Innovation Community
- Moffitt Study Shows Gene Expression Test Can Help Identify Melanoma Patients at Low Risk of Lymph Node Spread
- Pentecost Foundation Donates Another $10 Million to Moffitt Cancer Center, Fueling Unprecedented Push Toward a Myeloma Cure
- Moffitt Cancer Center and Dyve Biosciences Partner To Advance First-in-Human Studies Targeting Tumor Acidity
- Moffitt Studies Uncover Complementary Strategies to Overcome Resistance to KRAS G12C Inhibitors in Lung Cancer
- Moffitt Study Finds Promising First Evidence of Targeted Therapy for NRAS-Mutant Melanoma
- Moffitt Study Reveals Way to Spark Immune Hotspots That Attack Tumors
- Moffitt Cancer Center Earns 2025 Digital Health Most Wired Recognition
- Miles for Moffitt Presented by AutoNation Celebrates 20 Years on Saturday
- Moffitt Cancer Center Leads in IT Innovation and Workplace Excellence
- News Coverage